Novo Nordisk market cap surpasses Tesla on new obesity pill trial data

The logo of Danish pharmaceutical company is pictured at their headquarters in Bagsvaerd outside of Copenhagen, Denmark on February 1, 2017.Wegovy obesity drug maker Novo Nordisk surpassed Tesla in market value Thursday, after fresh early trial data showed positive results for its new experimental weight loss pill.Shares of the Danish company hit a record high in the previous session, rallying by as much as 8%, after telling investors that a Phase I trial of the company's amycretin pill showed 13.1% weight ...